Congratulations ILC4 Student/Postdoc Travel Award Winners

Mohammad Arifuzzaman 
Weill Cornell Medicine, Jill Roberts Institute, Dept. of Medicine
New York, United States
Presentation: P160 DIETARY FIBER PROMOTES MICROBIOTA-DERIVED BILE ACIDS AND TYPE 2 INFLAMMATION

Kyle Burrows 
University of Toronto,
Toronto, Canada
Presentation: O40 RBP/J REGULATES TISSUE SPECIFIC ADAPTATIONS OF GROUP 2 INNATE LYMPHOID CELLS

Michela Calvi 
University of Milan, Departmentof Medical Biotechnologies and Translational Medicine
Milan, Italy
Presentation: P331 ALTERED ILC DEVELOPMENTAL PATHWAYS IN MYELODYSPLASTIC SYNDROME PATIENTS

Kelly M Cautivo 
University of California San Francisco,
San Francisco, United States
Presentation: O15 TYPE 1 AND 2 LYMPHOCYTE NICHE BOUNDARIES DURING MIXED INFLAMMATION

Victor Cortez 
University of California San Francisco,
San Francisco, United States
Presentation: P162 CYTOKINE ACTIVATED ILC2 ESTABLISH AN INFLAMMATORY TISSUE MEMORY IN THE GUT

Sophie Curio 
University of Queensland, Diamantina Institute
Brisbane, Australia
Presentation: O70 THE NK CELL RECEPTOR NKG2D CONTRIBUTES TO TUMOR PROGRESSION IN MUCOSAL CANCERS BY DRIVING IL-17A-MEDIATED INFLAMMATION

Arundhoti Das 
National Institutes of Health, National Institutes of Health
Rockville, United States
Presentation: O59 TOX2 IS REQUIRED FOR METABOLIC ADAPTATION OF ILC3 IN GUT BUT NOT CENTRAL LYMPHOID TISSUES

Elia Charleen Diem 
Medical School Hanover, Institute for Medical Microbiology and Hospital Epidemiology
Hannover, Germany
Presentation: O101 THE EFFECT OF TISSUE ENVIRONMENT ON THE EPIGENETIC SIGNATURES IN HUMAN INNATE LYMPHOID CELLS (ILC)

Giuseppe Ercolano 
University of Naples Federico II, Department of Pharmacy
Naples, Italy
Presentation: P333 PPARƔ DRIVES IL-33-DEPENDENT ILC2 PRO-TUMORAL

FUNCTIONS

Brooke Elizabeth Fiedler 
Weill Cornell Medicine, Cornell University,
New York, United States
Presentation: O37 GROUP-3 INNATE LYMPHOID CELLS PROTECT FROM INTESTINAL INFLAMMATION VIA SYNDECAN-4

Christin Friedrich 
University Wuerzburg, Wuerzburg Institute of Systems Immunology
Wuerzburg, Germany
Presentation: O5 TISSUE NICHES AND TRANSCRIPTIONAL PROGRAMS REGULATING ILC1 DIFFERENTIATION DURING ONTOGENY AND INFECTION.

Mayuri Gogoi 
Laboratory of Molecular Biology MRC, PNAC
Cambridge, United Kingdom
Presentation: O86 ROLE FOR ILC2-DERIVED LEUKAEMIA INHIBITORY FACTOR (LIF) IN ACUTE TYPE 2 LUNG CHALLENGE.

Fabian Guendel 
Institut Pasteur, Immunology
Paris, France
Presentation: O83 GROUP 3 INNATE LYMPHOID CELLS PROGRAM A DISTINCT SUBSET OF IL-22BP-PRODUCING DENDRITIC CELLS DEMARCATING SOLITARY INTESTINAL LYMPHOID TISSUES.

Rama K Gurram 
NHLBI/NIH, Laboratory of Molecular Immunology
Bethesda, United States
Presentation: O85 TH2 CELL-DERIVED IL-4 INDUCES THE EXPRESSION OF TYPE 2 ALARMINS TO ACTIVATE PULMONARY ILC2S

Nicholas G. Herbert 
Africa Health Research Institute,
Morningside, Durban, South Africa
Presentation: P341 ILC3S IN HIV INFECTED LYMPH NODES UPREGULATE INFLAMMATORY PATHWAYS LINKED TO TISSUE FIBROSIS

Daniela Carolina Hernández Torres 
German Rheumatism Center, Innate Immunity
Berlin, Germany
Presentation: O7 IN VITRO GENERATION OF HUMAN INNATE LYMPHOID CELLS FROM TISSUE-DERIVED CD34+ HEMATOPOIETIC PROGENITORS

Morgan W.D. Heycock 
MRC – Laboratory of Molecular Biology,
Cambridge, United Kingdom
Presentation: O16 INNATE LYMPHOID CELLS ARISE EARLY IN THE FOETAL THYMUS ALONGSIDE DEVELOPING MEDULLARY THYMIC EPITHELIAL CELLS

Qiutong Huang 
The University of Queensland Diamantina Institute,
Brisbane, Australia
Presentation: O23 GFI1 CO-REGULATES EOMESODERMIN AND FOXO1 TO SCULPT NK CELL MATURATION AND FUNCTION.

Ranit Kedmi 
NYU Grossman School of Medicine, pathology
New York, United States
Presentation: O61 MICROBIOTA-INSTRUCTED REGULATORY T CELL DIFFERENTIATION IS MEDIATED BY A DISTINCT ANTIGEN PRESENTING CELL SUBSET

Satoshi Koga 
University of California San Francisco,
San Francisco, United States
Presentation: O14 SPATIAL AND FUNCTIONAL COMPARTMENTALIZATION OF SMALL INTESTINE GROUP 2 INNATE LYMPHOID CELLS (ILC2S)

Sonia Jessica Laurie 
UNC Chapel Hill School of Medicine, Microbiology & Immunology
Chapel Hill, United States
Presentation: O102 PRO-INFLAMMATORY EPIGENETIC CHANGES CONVERT TYPE 2 ILCS TO ILC1-LIKE CELLS FOLLOWING ALLOGENEIC HSCT

Chang Liao 
University of California San Francisco,
San Francisco, United States
Presentation: O82 TELOCYTE TSLP INITIATES THE ILC2-TUFT CELL SMALL INTESTINAL CIRCUIT IN RESPONSE TO FEEDING

Mengze Lyu 
Weill Cornell Medical College,
New York, United States
Presentation: O38 ILC3S SELECT FOR RORGT+ TREGS AND ESTABLISH TOLERANCE TO INTESTINAL MICROBIOTA

Nicholas M Mroz 
University of California, San Francisco,
San Francisco, United States
Presentation: P327 ILC2S LIMIT CORTICAL DAMAGE AND NEURONAL HYPEREXCITABILITY AFTER PHOTOTHROMBOTIC INJURY

Nils Christian Müller 
German Rheumatism Research Center DRFZ,
Berlin, Germany
Presentation: O84 EOMES+ NK CELL SUBSETS ACCUMULATE IN THE INTESTINAL LAMINA PROPRIA DURING INFLAMMATION

Pascal Naef 
University of California, Irvine, Biological Chemistry
Irvine, United States
Presentation: P169 IL-33 STIMULATED ILC2S REGULATE STEADY STATE AND DEMAND-ADAPTED MYELOPOIESIS

Ritsu Nagata 
Yokohama City University, Graduate School of Medical Life Science
Yokohama, Japan
Presentation: P155 ANALYSIS FOR INDUCTION MECHANISMS OF PERITONITIS REGULATED BY ADIPOSE TISSUE

Inga Rødahl 
Karolinska Institute, Department of Medicine Huddinge
Stockholm, Sweden
Presentation: P348 DISTINCT DEVELOPMENTAL AND TRANSCRIPTIONAL PATTERNS OF HUMAN INNATE LYMPHOID CELLS ACROSS FETAL TISSUES

Monica Romera Hernandez 
University of British Columbia, Pathology and Laboratory Medicine
Vancouver, Canada
Presentation: P141 LUNG-RESIDENT ILC3 ARE ESTABLISHED BY T LINEAGE-DERIVED CELLS

Endi Santosa 
Weill Cornell / Memorial Sloan Kettering,
New York, United States
Presentation: P157 IRF4 CONTROLS NK CELL CLONAL EXPANSION AND DIFFERENTIATION DURING VIRAL INFECTION

Julia Sbierski-Kind 
Medical Faculty- LMU Munich, Department for Endocrinology and Diabetes
Munich, Germany
Presentation: O96 GROUP 2 INNATE LYMPHOID CELLS SUPPRESS INNATE TYPE 3/17 RESPONSES IN HEPATIC FIBROSIS

Cyril Seillet 
Walter and Eliza Hall Institute of Medical Research, Immunology
Melbourne, Australia
Presentation: O98 PD-1 REGULATES ILC3-DRIVEN INTESTINAL IMMUNITY AND HOMEOSTASIS

Christina Stehle 
German Rheumatism Research Centre and Charité Berlin,
Berlin, Germany
Presentation: O4 ROLE OF T-BET, RORYT AND RORΑ IN REGULATING INTESTINAL EPITHELIAL DIFFERENTIATION AND HOMEOSTASIS

Laura Surace 
University of Bonn, ICCCP
Bonn, Germany
Presentation: O71 DISTINCT PATHWAYS REGULATE HUMAN ILC PROLIFERATION AND FUNCTION

Aydan C H Szeto 
Medical Research Council – Laboratory of Molecular Biology,
Cambridge, United Kingdom
Presentation: O47 CRISPR-MEDIATED GENOME-WIDE TRANSCRIPTION FACTOR SCREENING IDENTIFIES MEF2D AS A NOVEL REGULATOR OF ILC2 FUNCTION

Marijne Vermeer 
University of Zurich, Institute of Experimental Immunology
Zurich, Switzerland
Presentation: P338 THE PULMONARY ENDOTHELIUM ARMS NATURAL KILLER CELLS FOR ANTI-METASTATIC RESPONSES

Lorenz Wirth 
Karolinska Institutet and AstraZeneca,
Stockholm, Sweden
Presentation: O69 EICOSANOID METABOLISM AND FUNCTION IN HUMAN INNATE LYMPHOID CELLS

Mario Witkowski 
Charité Universitätsmedizin Berlin,
Berlin, Germany
Presentation: O60 POSTNATAL ILC HOMEOSTASIS AND FUNCTION IS CONTROLLED BY DISTINCT SUBSET-SPECIFIC MICRORNA REGULOMES

Pamela Wong 
Washington University in School of Medicine,
St. Louis, United States
Presentation: O25 SINGLE-CELL RNA-SEQUENCING ANALYSIS REVEALS T-BET AND EOMES ARE REQUIRED FOR MAINTAINING MATURE NK CELL TRANSCRIPTIONAL PROGRAM

Cong Xu 
University Hospital Erlangen, Internal Medicine 3
Erlangen, Germany
Presentation: O95 NOTCH-DEPENDENT IL9 SIGNALING IN ILC2 REGULATES FIBROSIS

Ming Xu 
UT Health San Antonio, MIMG
San Antonio, United States
Presentation: P328 ACTIVATION OF CD81+ SKIN ILC2S BY A COLD-SENSING TRPM8 – IL-18 AXIS REGULATES SKIN

BARRIER THERMAL HOMEOSTATIC REGULATION

Toshiki Yamada 
Akita University Graduate School of Medicine,
Akita, Japan
Presentation: P179 ACTIVATION-INDUCED CELL DEATH OF ILC2 REGULATES CHRONIC ALLERGIC INFLAMMATION

Hiroshi Yano 
Weill Cornell Medicine,
New York, United States
Presentation: O97 NEURONAL REGULATION OF NON-REDUNDANT FUNCTIONS OF INNATE LYMPHOID CELLS

Wenqing Zhou 
Weill Cornell Medical College, Medicine
New York, United States
Presentation: O94 ZBTB46 DEFINES AND REGULATES GROUP 3 INNATE LYMPHOID CELLS THAT PROTECT THE INTESTINE